This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top Analyst Reports for Visa, Charles Schwab & Amphenol
by Mark Vickery
Analysts spotlight fresh insights on Visa, Schwab and Amphenol, with new data on growth drivers, risks and market performance.
Autoscope Technologies Posts Q3 Loss, Sharp Y/Y Revenue Drop
by Zacks Equity Research
AATC's Q3 results reflect a steep y/y revenue decline, a swing to a loss and transitional challenges as customers shift to the new OptiVu platform.
Revisiting 5 Small Cap AI Stocks: Still Buys?
by Tracey Ryniec
Mark Zinski, Zacks Small Cap Stock Analyst, returns to review AI stocks from prior podcast episodes.
Autoscope Q2 Earnings Fall 50% Y/Y as Revenues Drop Amid Product Shift
by Zacks Equity Research
AATC Q2 earnings plunge 50% y/y on lower royalties and sales, but management sees growth ahead with new product adoption and stable cost controls.
The Zacks Analyst Blog Highlights Johnson & Johnson, The Home Depot, Micron Technology, Autoscope Technologies and Nova LifeStyle
by Zacks Equity Research
JNJ, HD, MU, AATC, and NVFY stand out with strong gains and strategic shifts amid macro headwinds and evolving consumer demand.
Top Analyst Reports for Johnson & Johnson, Home Depot and Micron
by Mark Vickery
MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.
Zacks Market Edge Highlights: Autoscope and Duos
by Zacks Equity Research
Zacks Market Edge spotlights small-cap AI plays Autoscope (AATC) and Duos (DUOT), with smart tech, strong margins, and revenue growth on the radar.
2 Small Cap AI Stocks for Your Watch List
by Tracey Ryniec
Mark Zinski, Zacks Small Cap Analyst, is back with another 2 companies involved in the AI Revolution.
Autoscope Q1 Earnings Fall 58% Y/Y as Royalties Dip, New Products Rise
by Zacks Equity Research
AATC sees improved margins and rising product sales, signaling early traction from recent launches despite softer revenues and earnings in the first quarter.
Autoscope Earns Outperform Rating on Yield, Growth & Valuation Upside
by Zacks Equity Research
Autoscope has been upgraded to "Outperform" on 7% yield, federal tailwinds, high-margin product growth, strong cash flow and deep valuation discount at 6X EBITDA, with $7 million in liquidity.